佳礼资讯网

 找回密码
 注册

ADVERTISEMENT

【FINTEC 0150 交流专区】(前名 ASIABIO)

  [复制链接]
发表于 29-11-2012 12:09 AM | 显示全部楼层
亚洲生化私配3820万股

财经新闻 财经  2012-12-01 11:57
(吉隆坡30日讯)亚洲生化(AsiaBio,0150,创业板)建议私下配售最高3820万股新普通股,每股面值10仙,相等于10%缴足股本。

截至今日,公司缴足股本为3820万令吉,包括3亿8200万股。

亚洲生化有意透过西金(KAF)把上述新股配售给第三方投资者。

公司也预计,假设私下配售新股的参阅价为每股10仙,私下配售活动将可筹措382万令吉。[Nanyang]
ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR THE “COMPANY”)
• PROPOSED PRIVATE PLACEMENT
On behalf of the Board of Directors of AsiaBio, KAF Investment Bank Berhad wishes to announce that the Company is proposing to undertake the Proposed Private Placement (as defined in the attached complete announcement).
Attachments

本帖最后由 icy97 于 1-12-2012 12:41 PM 编辑

回复

使用道具 举报


ADVERTISEMENT

发表于 30-11-2012 12:58 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31/10/2012
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/10/2012
31/10/2011
31/10/2012
31/10/2011
$$'000
$$'000
$$'000
$$'000
1Revenue
274
1,497
1,367
5,119
2Profit/(loss) before tax
-434
-686
-2,227
315
3Profit/(loss) for the period
-449
-708
-2,242
258
4Profit/(loss) attributable to ordinary equity holders of the parent
-458
-916
-2,233
1,349
5Basic earnings/(loss) per share (Subunit)
-0.12
-0.25
-0.58
0.37
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.0588
0.0644

回复

使用道具 举报

发表于 11-12-2012 09:41 AM | 显示全部楼层
亚洲生化卖Platinum Nanochem 1.56% 换英国Biofutures 1.08%

财经新闻 财经  2012-12-12 11:48
(吉隆坡11日讯)亚洲生化(AsiaBio,0150,创业板)建议脱售旗下Platinum Nanochem私人有限公司的1.56%股权,换取英国上市公司Biofutures国际、价值99万9107英镑(约484万1673令吉)的1.08%股权。

亚洲生化今天发文告宣布,与多名卖家透过换股方式,脱售Platinum Nanochem私人有限公司,予伦敦另类投资市场(AIM)上市的Biofutures国际。

Biofutures国际将以价值8080万8081英镑(约3亿9150万令吉)的新股,支付有关卖家,包括持有Platinum Nanochem私人公司1.56%股权的亚洲生化。

因此,亚洲生化完成脱售后,将持有Biofutures国际的1.08%股权。英国上市的Biofutures国际,主要业务为投资或收购能源或水电公司。

亚洲生化指出,上述脱售行动是要促进Platinum Nanochem私人公司倒置收购Biofutures国际,以在伦敦另类投资市场上市,并获得更多资金协助扩展业务。

“完成后,脱售行动估计可为我们带来465万令吉净收入,或增加每股净资产约1.22仙。”

截至2011年12月31日,Platinum Nanochem私人公司写下高达3202万5492令吉的净亏损。同时,Biofutures国际则创下1393万8000英镑净亏损。

亚洲生化预期未来4个月内完成脱售行动。另外,亚洲生化今天早上9时8分宣告暂停交易,直至早上10时8分恢复交易。

闭市时,亚洲生化并没有太大波动,以7仙平盘挂收,成交量有52万9800股。[Nanyang]
ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR “THE COMPANY”)
- PROPOSED DISPOSAL OF 1,143,434 ORDINARY SHARES OF RM1.00 EACH, REPRESENTING 1.56% OF THE TOTAL ORDINARY SHARES, IN PLATINUM NANOCHEM SDN BHD (FORMERLY KNOWN AS PLATINUM ENERGY SDN BHD) TO BIOFUTURES INTERNATIONAL PLC (“BIP”) FOR A TOTAL CONSIDERATION OF £999,107 (EQUIVALENT TO RM4,841,673) (“PROPOSAL”)
The Board of Directors of ABT wishes to announce the execution of a Share Sale Agreement (“SSA”) on 10 December 2012 between Biofutures International Plc. (“BIP”) and the various vendors of Platinum Nanochem Sdn Bhd (formerly known as Platinum Energy Sdn Bhd) (“PNSB”), including ABT (hereinafter referred to as the “Vendors”), for the sale by the Vendors and the purchase by BIP of the entire issued share capital of PNSB comprising of 73,481,290 ordinary shares of RM1.00 each, 4,000,000 redeemable convertible cumulative preference shares of RM0.10 each (“RCCPS”) and 15,000,000 redeemable convertible cumulative preference shares of RM1.00 each (“RCCPS B”) (hereinafter referred to as “Sale Shares”), for a total consideration of £80,808,081 (“Purchase Price”) to be satisfied by the issuance of 1,154,401,154 fully paid, new ordinary shares in the share capital of BIP (“Consideration Shares”).

This announcement is dated 11 December 2012.
Attachments

本帖最后由 icy97 于 12-12-2012 01:18 PM 编辑

回复

使用道具 举报

发表于 18-12-2012 10:00 PM | 显示全部楼层
icy97 发表于 29-11-2012 12:09 AM
亚洲生化私配3820万股

财经新闻 财经  2012-12-01 11:57

ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR THE “COMPANY”)
•        PROPOSED PRIVATE PLACEMENT OF UP TO 38,200,000 NEW ORDINARY SHARES OF RM0.10 EACH IN ASIABIO REPRESENTING UP TO TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF ASIABIO (“PROPOSED PRIVATE PLACEMENT”)
We refer to the announcement dated 28 November 2012 in relation to the Proposed Private Placement.

On behalf of the Board of Directors of AsiaBio, KAF Investment Bank Berhad wishes to announce further information of the Proposed Private Placement.


This announcement is dated 18 December 2012.
Attachments

回复

使用道具 举报

发表于 18-1-2013 12:37 AM | 显示全部楼层
亞洲生物能源600萬售eCompazz IT 28%

大馬  2013-01-18 17:39
(吉隆坡18日訊)亞洲生物能源(ASIABIO,0150,創業板貿服組)以600萬令吉,脫售eCompazz IT公司的28%股權。

該公司發文告指出,由於eCompazz IT公司前景充滿挑戰,而且不再是業務焦點,因此決定展開脫售行動。

另外,亞洲生物能源也與Nexfuel及Hexa Bonanza公司聯營合作發展生物質混合物粒化業務,其中亞洲生物能源初步階段將祭出290萬令吉資金,並持有該聯營計劃的50.1%股權。(星洲日報/財經)

ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR “THE COMPANY”)

PROPOSED DISPOSAL OF 28% EQUITY STAKE IN ECOMPAZZ IT SDN BHD COMPRISING 84,000 ORDINARY SHARES OF RM1.00 EACH TO THE PURCHASERS, LIM HAI TENG AND LIM CHEOW CHUEN, FOR A CASH CONSIDERATION AMOUNT OF RM6,000,000
The Board of Directors of ABT wishes to announce that the Company, as the Vendor, has on 17 January 2013 entered into a Share Sale Agreement with Lim Hai Teng and Lim Cheow Chuen as the Purchasers, for the disposal of a 28% equity stake in eCompazz IT Sdn Bhd comprising 84,000 ordinary shares of RM1.00 each for a cash consideration sum of RM6,000,000.

This announcement is dated 17 January 2013.
Attachments

本帖最后由 icy97 于 22-1-2013 10:34 PM 编辑

回复

使用道具 举报

发表于 18-1-2013 12:38 AM | 显示全部楼层

ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR “THE COMPANY”)

PROPOSED JOINT VENTURE BETWEEN ABT, NEXFUEL SDN BHD (“NEXFUEL”) AND HEXA BONANZA SDN BHD (“HEXA”) ON THE DEVELOPMENT OF HEXA’S BIOMASS COMPOST PELLETIZING BUSINESS USING OIL PALM TRUNK PEELED LUMBER MACHINE AND TECHNOLOGY SUPPLIED BY NEXFUEL
The Board of Directors of ABT wishes to announce the execution of a Joint Venture Agreement (“JVA”) on 17 January 2013 between ABT, Nexfuel as the technology provider and Hexa as the special purpose vehicle on the joint venture to develop Hexa’s biomass compost pelletizing business using Nexfuel’s oil palm trunk peeled lumber machine and technology and to carry out the research and development of technologies relating to such (hereinafter referred to as the “JV Project”).  

The JV Project is a “green” initiative since it aims to convert biomass from oil palm logs after its felling for replanting exercise into peeled lumber, which when combined with veneer can be used to produce block board panels for the building materials industry.

This announcement is dated 17 January 2013.
Attachments

本帖最后由 icy97 于 22-1-2013 10:34 PM 编辑

回复

使用道具 举报

Follow Us
发表于 22-1-2013 10:32 PM | 显示全部楼层
ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR “THE COMPANY”)
- PROPOSED DISPOSAL OF 28% EQUITY STAKE IN ECOMPAZZ IT SDN BHD COMPRISING 84,000 ORDINARY SHARES OF RM1.00 EACH TO THE PURCHASERS, LIM HAI TENG AND LIM CHEOW CHUEN, FOR A CASH CONSIDERATION AMOUNT OF RM6,000,000 (“PROPOSED DISPOSAL”)
We refer to Section 2.3 of the Company’s announcement dated 17 January 2013 on the Proposed Disposal.

We wish to clarify that the Purchase Price was arrived at on negotiated, willing-buyer willing-seller basis based on the audited net assets of eCompazz group of companies as at 31 January 2012 of approximately RM2.3 mil and taking into consideration of the audited profit after tax of RM3.2 mil for the financial year ended 31 January 2012, as well as the prospects of eCompazz in the future.  The Purchase Price arrived at represents a PE multiple of about 6.7 times the audited profits of eCompazz for the latest financial year ended 31 January 2012.

This announcement is dated 22 January 2013.

回复

使用道具 举报

发表于 22-1-2013 10:35 PM | 显示全部楼层
icy97 发表于 18-1-2013 12:38 AM

ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ABT” OR “THE COMPANY”)
- PROPOSED JOINT VENTURE BETWEEN ABT, NEXFUEL SDN BHD (“NEXFUEL”) AND HEXA BONANZA SDN BHD (“HEXA”) ON THE DEVELOPMENT OF HEXA’S BIOMASS COMPOST PELLETIZING BUSINESS USING OIL PALM TRUNK PEELED LUMBER MACHINE AND TECHNOLOGY SUPPLIED BY NEXFUEL (“JV PROJECT”)
We refer to section 2.6 of the Company’s announcement on the JV Project dated 17 January 2013 (hereinafter referred to as “JV Project Announcement”).

We wish to clarify that the amount of balance of the deferred consideration payable to Liew Yeow Hooi and Chew Ean Nar by ABT, as disclosed in Section 2.6 of the JV Project Announcemnet being mutually waived off is amounting to RM3,250,000.

This annoucement is dated 22 January 2013.
回复

使用道具 举报


ADVERTISEMENT

发表于 13-3-2013 01:57 AM | 显示全部楼层
宜鼎機械與亞洲生物能源‧聯營生物科技業務

大馬  2013-03-13 11:25
(吉隆坡13日訊)宜鼎機械(AT,0072,創業板工業產品組)與亞洲生物能源(ASIABIO,0150,創業板貿服組)簽署合作協議,以合作供應將廚餘轉化成有機廢料的生物科技解決方案。

該公司發文告表示,根據協議,公司將負責製造和生產與維修堆肥機械(Composting Machine),以及取得有關當局對工程的審批,而亞洲生物能源則將負責提供將廚餘轉換成有機廢料的必要微生物解決方案和確認堆肥機械的設計。(星洲日報/財經)

ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR THE “COMPANY”)
- JOINT COLLABORATION AGREEMENT BETWEEN THE COMPANY AND AT SYSTEMIZATION BERHAD
The Board of Directors of Company is pleased to announce that the Company has on 11 March 2013, entered into a Joint Collaboration Agreement with AT Systemization Berhad (“AT”) to set out of the terms of their intention to collaborate in the supply biotechnology solutions to schools, government bodies, military bases, national service camps, colleges and universities in Malaysia to convert food waste to organic fertilizer (hereinafter referred to as“the Project”).

AT, which is listed on Bursa Securities, is involved in the fabrication of industrial and engineering parts and design and manufacture of industrial automation system and machinery.  AT, via its subsidiary AT Engineering Solution Sdn Bhd, has submitted a proposal to the Education Ministry of Malaysia for the implementation of a food waste conversion system using biotechnology at schools in Malaysia.

The intention of the parties under the Joint Collaboration Agreement is to work together wherein AT shall be responsible for the fabrication and manufacture and maintenance of the composting machineries as well as secure the approval of the relevant authorities for the Project and Asiabio, via its wholly owned subsidiary company, Hexa Bonanza Sdn Bhd, shall be responsible for the provision of the microbial solutions necessary for the conversion of the food waste into organic fertilizer as well as identification of the composting machinery design for the fabrication by AT.

The Joint Collaboration Agreement shall take effect on the date of its execution and shall continue to be of effect until the execution of a definitive agreement, which the parties agree to execute within three (3) months from the date of the Joint Collaboration Agreement.

This announcement is dated 12 March 2013.

本帖最后由 icy97 于 13-3-2013 10:38 PM 编辑

回复

使用道具 举报

发表于 27-3-2013 01:01 AM | 显示全部楼层
icy97 发表于 11-12-2012 09:41 AM
亚洲生化卖Platinum Nanochem 1.56% 换英国Biofutures 1.08%

财经新闻 财经  2012-12-12 11:48

ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR “COMPANY”)
PROPOSED DISPOSAL OF 1,143,434 ORDINARY SHARES OF RM1.00 EACH, REPRESENTING 1.56% OF THE TOTAL ORDINARY SHARES, IN PLATINUM NANOCHEM SDN BHD (FORMERLY KNOWN AS PLATINUM ENERGY SDN BHD) TO BIOFUTURES INTERNATIONAL PLC (“BIP”) (“PROPOSAL”)
Reference is made to the Company’s announcement on 11 December 2012 and 17 December 2012 on the proposed disposal of 1,143,434 ordinary shares of RM1.00 each in Platinum Nanochem Sdn Bhd (“PNSB”) to Biofutures International PLC (“BIP”) (“Proposal”).

We have on 26 March 2013, received notification from PNSB that the shareholders of BIP have vide an Extraordingary General Meeting held on 25 March 2013 approved the proposed acquisition of PNSB, with a revision to the number of shares to be issued as consideration. Pursuant thereto, the vendors of PNSB have executed supplemental documents wherein Asia Bioenergy Technologies Berhad will receive 21,018,714 new ordinary shares of BIP (“Said Shares”) which Total Platinum Holdings Sdn Bhd, the main promoter of PNSB having a 12-month option to acquire the Said Shares at a price of £0.06 per share (“Share Price”) i.e. a total consideration of £1,261,123 (or RM 5,873,049 based on an exchange rate of £1:RM4.657).

The Share Price of £0.06 per share represents a discount of 9.4% over the last five (5) days weighted average market price of BIP shares up to 25 March 2013 of approximately £0.06565 per share, the last practicable date prior to the date of this announcement.

In view of the above, the Proposal will result in a revised gain on disposal of PNSB of RM5,683,654 to AsiaBio Group.

The highest percentage ratio applicable to the Amended Agreement and Option Agreement pursuant to Rule 10.02(g) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad is 24.05%.

All other salient features of the Proposal remain the same per the original announcement. The Proposal have also been completed on 26 March 2013 with the re-admission of BIP under its new name of Graphene NanoChem Plc.

Copies of the Amended Agreement and Option Agreement are available for inspection at the registered office of ABT during normal business hours from Monday to Friday (except public holidays) at B-11-10, Megan Avenue II, Jalan Yap Kwan Seng, 50450 Kuala Lumpur for a period of 3 months from the date of this announcement.

This announcement is dated 26 March 2013.

回复

使用道具 举报

发表于 29-3-2013 08:47 PM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31/01/2013
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/01/2013
31/01/2012
31/01/2013
31/01/2012
$$'000
$$'000
$$'000
$$'000
1Revenue
946
398
2,313
5,517
2Profit/(loss) before tax
-2,090
-18,666
-4,317
-18,351
3Profit/(loss) for the period
-2,161
-18,701
-4,403
-18,443
4Profit/(loss) attributable to ordinary equity holders of the parent
-2,161
-18,601
-4,394
-19,950
5Basic earnings/(loss) per share (Subunit)
-0.57
-5.08
-1.15
-5.45
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.0531
0.0644

回复

使用道具 举报

发表于 29-3-2013 08:48 PM | 显示全部楼层
ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIABIOENERGY TECHNOLOGIES BERHAD ("ASIABIO OR THE "COMPANY")

ACQUISITION OF REMAINING SHARES IN SUBSIDIARY
1. Introduction
We wish to announce that Asiabio has today acquired the remaining 20,000 ordinary shares of RM1.00 each representing 20.0% of the issued and paid-up capital of Eco-Sponge Sdn Bhd (“Eco-Sponge”), an existing subsidiary of Asiabio, from the vendor, Tan KiatPoh, for a cash consideration amount of RM2.00 only (“Acquisition”).  With the acquisition of the remaining shares, Asiabio has increased its shareholding in Eco-Sponge to 100%.  

2. Information on Eco-Sponge
Eco-Sponge was incorporated in Malaysia under the Companies Act 1965 on 21 August 2007 and is involved in the manufacturing of absorbent filtration compound for the biodiesel industry. It is presently inactive.

3. Purchase Consideration
The purchase consideration was arrived at after taking into consideration the inactive status of the company as well as its audited net liabilities of RM24,275 and net losses of RM16,845 for the financial year ended 31 January 2012.

4. Rationale of the Acquisition
The Acquisition will give Asiabio full control of the company and its business, the direction and prospect of which will be determined later.

5. Financial Effects
The Acquisition is not expected to have any material effect on the earnings per share of Asiabio Group for the financial year ending 31 January 2014, share capital, major shareholders’ shareholdings, net assets per share, gearing and dividend policy of Asiabio Group.  Nonetheless, barring any unforeseen circumstances, the Acquisition is expected to contribute positively to the future earnings of the Company upon successful implementation of the business turnaround of Eco-Sponge.

There are no liabilities, including contingent liabilities or guarantees,expected to be assumed by Asiabioor the vendor from the Acquisition.

6. Percentage Ratio
The highest percentage ratio applicable to the Acquisition is negligible.

7. Directors’ and Major Shareholders’ Interest
None of the Directors, substantial shareholders and/or persons connected with the Directors and/or substantial shareholders of Asiabio has any interest, direct or indirect, in the Acquisition.

8. Statement by Directors
The Board of Directors of Asiabio is of the opinion that the Acquisition is in the best interest of Asiabio.

9. Approvals
The Acquisition is not subject to the approval of shareholders and regulatory authorities.

This announcement is dated 28 March 2013.

回复

使用道具 举报

发表于 3-4-2013 06:31 PM | 显示全部楼层
ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Reply to query
Reply to Bursa Malaysia's Query Letter - Reference ID
NS-130401-42025
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD ("ASIABIO" OR "COMPANY")
PROPOSED DISPOSAL OF 1,143,434 ORDINARY SHARES OF RM1.00 EACH, REPRESENTING 1.56% OF THE TOTAL ORDINARY SHARES, IN PLATINUM NANOCHEM SDN BHD ("PNSB") (FORMERLY KNOWN AS PLATINUM ENERGY SDN BHD) TO BIOFUTURES INTERNATIONAL PLC ("BIP") ("PROPOSAL")


We refer to the query letter from Bursa Malaysia Securities Berhad dated 1 April 2013.

In reply to the query, we wish to clarify that pursuant to the supplemental documents between the vendors of Platinum NanoChem Sdn Bhd (“PNSB”) and Biofutures International Plc (“BIP”) as announced on 26 March 2013, Asiabio will receive an increase in the number of consideration shares of BIP, totaling 21,018,714 new ordinary shares ("Consideration Shares") in exchange for the 1,143,434 ordinary shares in PNSB.  The issue price of the consideration shares of BIP remains unchanged at £0.07 per share as per the announcement dated 11 December 2012, resulting in a deemed consideration of £1,471,310 or RM6,851,890 based on the exchange rate of £1:RM4.657.

However, under the revised arrangement, Asiabio also executed an option agreement with Total Platinum Holdings Sdn Bhd ("TPH"), whereby an option is given to TPH to acquire the said Consideration Shares at £0.06 per share i.e. a total consideration of £1,261,123 (or RM5,873,049) for a six (6) months period commencing from the expiry of the 12-month lock-in period.  Upon expiry of the option period, if Asiabio intends to sell the Consideration Shares, Asiabio shall offer to TPH the first right of refusal to purchase at £0.06 per share, exercisable within six (6) months from the expiry of the option period.

In view of the option agreement, and in compliance with requirements of Rule 10.03 (5) of Chapter 10 of the ACE Market Listing Requirements, the consideration sum of RM5.8 million calculated based on the option price of £0.06 per share was disclosed.

This announcement is dated 2 April 2013.
回复

使用道具 举报

发表于 9-4-2013 02:23 AM | 显示全部楼层
icy97 发表于 27-3-2013 01:01 AM

ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD ("ASIABIO" OR "THE COMPANY")
DISPOSAL OF 1,143,434 ORDINARY SHARES OF RM1.00 EACH, REPRESENTING 1.56% OF THE TOTAL ORDINARY SHARES, IN PLATINUM NANOCHEM SDN BHD (FORMERLY KNOWN AS PLATINUM ENERGY SDN BHD) TO BIOFUTURES INTERNATIONAL PLC (“BIP”) (“DISPOSAL”)
We refer to our announcement dated 26 March 2013.


We wish to announce on behalf of the Board of Directors of the Company that Bursa Malaysia Securities Berhad ("Bursa Malaysia") has informed that since Asiabio has received a total of 21,018,714 new ordinary shares in Biofutures International PLC (“BIP”) issued at a price of £0.07 per BIP share, the deemed consideration for the disposal of 1,143,434 ordinary shares of RM1.00 each, representing 1.56% of the total ordinary shares, in Platinum NanoChem Sdn Bhd (“Disposal”) should be taken as £1,471,310 (or RM6,851,890 based on the exchange rate of £1:RM4.657).


The option agreement with Total Platinum Holdings Sdn Bhd (“TPHSB”) whereby an option has been granted to TPHSB to acquire the Consideration Shares at £0.06 per share is to be regarded as a separate and distinct transaction.

Based on the above, the highest applicable percentage ratio for the Disposal is 27.8%.  Therefore, shareholders’ approval is required for the Disposal.


In connection with the above, we wish to announce that the Company has on even date written in to Bursa Malaysia to seek for a waiver on the requirement for the shareholders’ approval and sponsor/advisor for proposals involving the disposal of assets in part or as whole due to a listing exercise or reverse takeovers, inclusive of the Disposal, failing which the right to ratify the transaction at an Extraordinary General Meeting to be convened.


The Company shall make an appropriate announcement on the decision taken by Bursa Malaysia upon receiving the outcome.


This announcement is dated 8 April 2013.

回复

使用道具 举报

发表于 4-5-2013 05:32 PM | 显示全部楼层
ASIA BIOENERGY TECHNOLOGIES BERHAD

Particulars of substantial Securities Holder
Name
Looi Kem Loong
Address
No. 48 Jalan Hujan Bubuk 3
Overseas Union Garden
Bt 5, Jalan Klang Lama
58200 Kuala Lumpur
NRIC/Passport No/Company No.
751224-07-5659
Nationality/Country of incorporation
Malaysia
Descriptions (Class & nominal value)
Ordinary Shares of RM0.10 each
Name & address of registered holder
Acritaz Holdings Sdn Bhd
A-3A-09 Oasis Ara Damansara
2 Jalan PJU 1A/7A
47301 Petaling Jaya
Selangor
Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transactionDate of change
No of securities
Price Transacted (RM)
Disposed30/04/2013
50,000,000
0.070

Circumstances by reason of which change has occurred
Disposal of shares
Nature of interest
Indirect
Direct (units)
733
Direct (%)
0
Indirect/deemed interest (units)
30,704,333
Indirect/deemed interest (%)
8.04
Total no of securities after change
30,705,066
Date of notice
03/05/2013

回复

使用道具 举报

发表于 11-5-2013 01:20 PM | 显示全部楼层
福泰中国投资控股 晋亚洲生化大股东

财经新闻 财经  2013-05-11 10:50
(吉隆坡10日讯)福泰中国投资控股有限公司(CPE)以350万令吉收购亚洲生化(AsiaBio,0150,创业板)13%持股权,晋身为大股东。

亚洲生化向马交所报备,福泰中国投资控股透过旗下位于香港的CPE GrowthCapital有限公司在4月30日收购亚洲生化5000万股票,持股比例相等于13%。

虽亚洲生化未透露交易价,但根据福泰中国投资本月8日发布在官网的文告,公司以每股7仙的价格收购亚洲生化13.08%股权,总值350万令吉。

大马市场对福泰中国投资控股并不陌生,较早前,公司购入巴迪玛斯(Patimas,7042,主板科技股)近5.1%股权,晋身大股东行列。

福泰中国投资执行主席约翰克拉夫指出,公司一直致力在亚洲寻找投资机会,特别是金融服务或是TMT行业(指融合高科技、传媒、电信)领域,而亚洲生化核心业务与资讯科技和生物科技相关。[南洋网财经]

Name
CPE GROWTH CAPITAL LIMITED
Address
16/F CHUNG NAM BUILDING
1 LOCKHART ROAD, WANCHAI
HONG KONG
NRIC/Passport No/Company No.
1709460
Nationality/Country of incorporation
BRITISH VIRGIN ISLANDS
Descriptions (Class & nominal value)
Ordinary Shares of RM0.10 each
Name & address of registered holder
CPE GROWTH CAPITAL LIMITED
16/F CHUNG NAM BUILDING
1 LOCKHART ROAD, WANCHAI
HONG KONG
Date interest acquired & no of securities acquired
Currency
Malaysian Ringgit (MYR)
Date interest acquired
30/04/2013
No of securities
50,000,000
Circumstances by reason of which Securities Holder has interest
Portfolio investment
Nature of interest
Direct
Price Transacted ($$)

Total no of securities after change
Direct (units)
50,000,000
Direct (%)
13.08
Indirect/deemed interest (units)

Indirect/deemed interest (%)
Date of notice
07/05/2013

本帖最后由 icy97 于 11-5-2013 10:24 PM 编辑

回复

使用道具 举报


ADVERTISEMENT

发表于 13-5-2013 02:28 PM | 显示全部楼层
icy97 发表于 11-5-2013 05:20 AM
福泰中国投资控股 晋亚洲生化大股东

财经新闻 财经  2013-05-11 10:50
@williamnkk81
如何看待这公司??早前CPE GrowthCapital购入巴迪玛斯(Patimas,7042,主板科技股)近5.1%股权后Patimas股价好像去参加中国星跳跃酱呢。。。十米高台往下跳
本帖最后由 icy97 于 13-5-2013 06:23 PM 编辑

回复

使用道具 举报

发表于 11-6-2013 01:30 AM | 显示全部楼层
亚洲生化与OVG及CPM签约 合作推出互动媒体平台

财经新闻 财经  2013-06-12 11:20
(吉隆坡11日讯)亚洲生化(AsiaBio,0150,创业板)宣布,与Omni Ventures Global有限公司(简称OVG)和Hunan China Post Media有限公司(简称CPM)签署意向备忘录,合作推出互动媒体平台。

亚洲生化向马交所报备,昨天与OVG和CPM签署上述备忘录,共同草拟合作推出互动媒体平台的合约内容。

CPM筹资3000万

文告指出,CPM为中国邮政的间接联营子公司,拥有在全中国邮局分局内,安装、持有和营运电子广告网络平台的特权,为期10年。

截至目前,CPM已经在中国部分地区的3000家邮局分局内,安装被动式的电子网络平台,并有意提升为互动电子网络平台,以提供额外服务。

CPM就此表示,有意寻找海外合作伙伴进行上述拓展计划,并筹资1000万美元(约3000万令吉)将该服务推向尚未进军的区域。[中国报财经]

Type
Announcement
Subject
OTHERS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR THE “COMPANY”)
MEMORANDUM OF INTENT BETWEEN THE COMPANY, OMNI VENTURES GLOBAL LTD AND HUNAN CHINA POST MEDIA LIMITED (“CPM”) FOR COLLABORATION AND INVESTMENT INTO CPM
The Board of Directors of the Company wishes to announce that the Company has on 10 June 2013, entered into a Memorandum of Intent with Omni Ventures Global Ltd (“OVG”) and Hunan China Post Media Limited (“CPM”) to set out of the terms of their collaboration in the launch of interactive media platform using CPM’s rights within the perimeters of the memorandum (hereinafter referred to as “the Project”).

OVG is an investment company incorporated in British Virgin Island and specializes in marketing and promotions in Hong Kong and China whereas CPM is an indirect associated company of China Post, the national post agency in China.

CPM holds the rights to install, own and operate in-store digital network that provides point of sale advertising platform at China Post’s outlets throughout China for ten (10) years (“Media Rights”) and has to date rolled out installation at some 3,000 outlets in certain districts in China. CPM also intends to rollout interactive kiosks operate along side with the existing passive in-store digital media platform that provides video advertising services, the expansion is to enable an interactive media platform that is able to provide additional services (“Expansion Plans”).
CPM intends to restructure via a holding company (“HoldCo”) to be incorporated offshore with the intention to raise further funding of an estimated sum of USD10 million for its expansion into other districts in China, with an ultimate intention of seeking a listing on a recognized stock exchange.

The salient terms of the Memorandum of Intent are as follows:-
• OVG shall provide its expertise, contacts and know-how in the Expansion Plans.
• OVG and AsiaBio to secure the required funding of USD10 million either by way of direct investment or acquisition from certain shareholders or other means mutually agreeable.
• CPM shall allow Omni and/or AsiaBio access to any material or parties necessary to conduct an operational and financial due-diligence.
• CPM shall detail out the proposed utilization of the funds required estimated at USD10 million.
• Via a legal due diligence to be performed, CPM shall prove to OVG and AsiaBio that their existing Media Rights also cover China Post’s kiosks outlets and installation of the interactive platform as aforementioned, unless otherwise waived mutually.

The Memorandum of Intent shall take effect on the date of its execution and shall be valid for a period of six (6) months.  In the initial three (3) months, the parties shall negotiate with each other on an exclusive basis and with first right for the balance three (3) months, within which the parties shall endeavor to execute a definitive investment and shareholders’ agreement based on this Memorandum of Intent.

This announcement is dated 10 June 2013.
本帖最后由 icy97 于 12-6-2013 05:38 PM 编辑

回复

使用道具 举报

发表于 11-6-2013 02:09 AM | 显示全部楼层
ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR THE “COMPANY”)a
• PRIVATE PLACEMENT
We refer to the Company’s previous announcements in relation to the private placement of up to ten percent (10%) of the issued and paid-up share capital of AsiaBio (“Private Placement”). For consistency purposes, the abbreviations and definitions used throughout this announcement are the same as those previously defined in the Company’s announcement dated 28 November 2012.
  
On behalf of the Board of Directors of AsiaBio, KAF is pleased to announce that the Company has fixed the issue price for the Private Placement comprising 38,200,000 Placement Shares at RM0.10 per Placement Share. The said issue price of RM0.10 per Placement Share represents a discount of approximately 7.15% from the five (5)-day weighted average market price of AsiaBio Shares up to and including 7 June 2013 of approximately RM0.1077 per AsiaBio Share as traded on Bursa Securities.
  
This announcement is dated 10 June 2013.


回复

使用道具 举报

发表于 13-6-2013 12:00 PM | 显示全部楼层
ASIA BIOENERGY TECHNOLOGIES BERHAD

Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS
Description
ASIA BIOENERGY TECHNOLOGIES BERHAD (“ASIABIO” OR THE “COMPANY”)
PROPOSED DISPOSAL BY ASIABIO OF 19.99% EQUITY INTEREST OF OVAL ALLIANCE SDN BHD (“OVAL”) COMPRISING 500,000 ORDINARY SHARES OF RM1.00 EACH FOR A CASH CONSIDERATION OF RM550,000 (“PROPOSED DISPOSAL”)

This announcement is dated 12 June 2013.
Attachments

回复

使用道具 举报

您需要登录后才可以回帖 登录 | 注册

本版积分规则

 

ADVERTISEMENT



ADVERTISEMENT



ADVERTISEMENT

ADVERTISEMENT


版权所有 © 1996-2023 Cari Internet Sdn Bhd (483575-W)|IPSERVERONE 提供云主机|广告刊登|关于我们|私隐权|免控|投诉|联络|脸书|佳礼资讯网

GMT+8, 29-3-2024 01:33 AM , Processed in 0.068880 second(s), 22 queries , Gzip On.

Powered by Discuz! X3.4

Copyright © 2001-2021, Tencent Cloud.

快速回复 返回顶部 返回列表